Sponsor:
UNC Lineberger Comprehensive Cancer Center
Code:
NCT06296368
Conditions
Hematologic Malignancies
Lymphoma
Multiple Myeloma
Leukemia
Blood Cancers
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
Preference Reporting to Improve Management and Experience (PRIME)
Brief summary:
Conditions
Hematologic Malignancies
Lymphoma
Multiple Myeloma
Leukemia
Blood Cancers
Study ID
NCT06296368
Start date
Jun 21, 2024
Status verified date
Aug, 2026
Completion date
Sep 1, 2028
Anticipated
Primary completion date
Sep 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Enrollment
500 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Health Services Research
Arms
no intervention: Usual Care
experimental: PRIME intervention
Interventions
Preference Reporting to Improve Management and Experience (PRIME)
Primary outcome measure
Central contacts
Locations
Lineberger Comphrehensive Cancer Center at University of North Carolina
Recruiting
Chapel Hill, North Carolina, United States, 27516
Contacts
Principal Investigator:
Daniel R Richardson,, MD, MA, MSc
Sponsor
UNC Lineberger Comprehensive Cancer Center
Last update posted
Aug 14, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center on 2026-08-14.